Philadelphia Pharmaceuticals PLC announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was JOD 4.353 million compared to JOD 4.485 million a year ago. Operating income was JOD 604,744 compared to JOD 887,273 a year ago. Net income was JOD 401,287 compared to JOD 703,344 a year ago. Basic earnings per share from continuing operations was JOD 0.053 compared to JOD 0.093 a year ago.